RASCHI, EMANUEL
RASCHI, EMANUEL
DIMEC - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di IIa fascia
Anticancer drugs and depression through the lens of disproportionality analysis: unveiling underlying confounders and tips for prescribers
2026 Raschi, E.; Nannini, M.; Montastruc, F.; Khouri, C.; Poluzzi, E.; De Ponti, F.
Contemporary local anaesthetic-associated adverse events and mortality: searching for the root causes of the pharmacovigilance signal. Br J Anaesth 2026;136:411–13
2026 Raschi, E.; Tonetti, T.; Khouri, C.; Poluzzi, E.; De Ponti, F.
Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation: To the Editor
2025 Raschi, E.; Squizzato, A.
Are Causal Statements Reported in Pharmacovigilance Disproportionality Analyses Using Individual Case Safety Reports Exaggerated in Related Citations? A Meta-epidemiological Study
2025 Bernardeau, Claire; Revol, Bruno; Salvo, Francesco; Fusaroli, Michele; Raschi, Emanuel; Cracowski, Jean-Luc; Roustit, Matthieu; Khouri, Charles
Attitudes, barriers, and facilitators toward tools supporting appropriate prescribing among healthcare professionals: a cross-sectional study
2025 Donati, M.; Giunchi, V.; Grillini, G.; Domenicali, M.; Lunardelli, M. L.; Pasini, V.; Milandri, S.; Mussoni, M.; Pieraccini, F.; Sangiorgi, E.; Raschi, E.; Colonnello, V.; Lunghi, C.; Poluzzi, E.
Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
2025 Cedirian, Stephano; Donati, Monia; Rapparini, Luca; Pampaloni, Francesca; La Placa, Michelangelo; Sgarzani, Rossella; Negosanti, Luca; Raschi, Emanuel; Starace, Michela
Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure
2025 Armillotta, Matteo; Angeli, Francesco; Paolisso, Pasquale; Belmonte, Marta; Raschi, Emanuel; Di Dalmazi, Guido; Amicone, Sara; Canton, Lisa; Fedele, Damiano; Suma, Nicole; Foà, Alberto; Bergamaschi, Luca; Pizzi, Carmine
Chat GPT and the Challenges to Detect Potential Drug–Drug Interactions Related to QT Prolongation
2025 Raschi, E.; Poluzzi, E.; De Ponti, F.
Comment on “evaluation of anticancer therapy-related dermatologic adverse events: insight from Food and Drug Administration’s adverse event reporting system dataset”.
2025 Raschi, E; La Placa, M; Starace, M.
Disproportionality analysis on semaglutide and nonarteritic anterior ischemic optic neuropathy in the FDA adverse event reporting system: An emerging pharmacovigilance signal?
2025 Procacci, Angela; Poluzzi, Elisabetta; De Ponti, Fabrizio; Raschi, Emanuel
FDA Adverse Event Reporting System Essentials: A Reflection on Study Conception
2025 Raschi, E.; Cutroneo, P.; Salvo, F.; Tuccori, M.; Khouri, C.
From adoption to impact: linking prescribing tools to clinical outcomes—authors’ response
2025 Donati, Monia; Lunghi, Carlotta; Grillini, Giulia; Domenicali, Marco; Lunardelli, Maria Lia; Pasini, Veronica; Milandri, Susy; Mussoni, Monica; Pieraccini, Fabio; Sangiorgi, Elisa; Raschi, Emanuel; Colonnello, Valentina; Poluzzi, Elisabetta
Gastrointestinal Perforations Associated With JAK Inhibitors: A Disproportionality Analysis of the FDA Adverse Event Reporting System
2025 Goldman, A.; Raschi, E.; Druyan, A.; Sharif, K.; Lahat, A.; Ben-Zvi, I.; Ben-Horin, S.
Ivabradine, atrial fibrillation and stroke: a combined meta-analysis and FAERS disproportionality analysis
2025 Spadotto, A.; Fusaroli, M.; Carelli, M.; Nardi, E.; Amadori, M.; Massaro, G.; De Angelis, V.; Gatti, M.; Ciubine, V.; Raschi, E.; Poluzzi, E.; Diemberger, I.
Letter to the Editor from Raschi et al: "endocrine Adverse Reactions of Tyrosine Kinase Inhibitors in Combination with Immune Checkpoint Inhibitors"
2025 Raschi, E.; Donati, M.; Salvo, F.; Khouri, C.
Long-term surveillance of the anti-amyloid monoclonal antibody lecanemab: rights and duties of pharmacovigilance
2025 Donati, Monia; Boccia, Angela; De Ponti, Fabrizio; Poluzzi, Elisabetta; Raschi, Emanuel
Safety of Hydroxychloroquine: What a Dermatologist Should Know
2025 Rapparini, Luca; Cedirian, Stephano; La Placa, Michelangelo; Piraccini, Bianca Maria; Raschi, Emanuel; Starace, Michela
The interface of depression and diabetes: treatment considerations
2025 Fanelli, G.; Raschi, E.; Hafez, G.; Matura, S.; Schiweck, C.; Poluzzi, E.; Lunghi, C.
Towards personalized therapy for atrial fibrillation: the rhythmic climbing of dronedarone
2025 Carelli, M.; Raschi, E.; Diemberger, I.
Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals
2024 Lunghi C.; Domenicali M.; Vertullo S.; Raschi E.; De Ponti F.; Onder G.; Poluzzi E.